Global Cannabis Stocks Decline Almost 5% in June

Cannabis sales are experiencing a global decline as of the end of last month.

Nineteen companies posted declines in excess of 15%, sixteen of them having primary listings in Canada

Eighteen companies posted gains in excess of only 5%

Cannabis stocks, as measured by the Global Cannabis Stock Index, fell again in June, declining 4.5% to 100.12, after going into the final week of the month with a small gain:

The index, which had 68 qualifying members that were equally weighted at the time of the prior rebalancing in March, declined 24.5% in the first three months of the year and, after another 7.2% decline in Q2, has now decreased 29.5% in the first half of 2018. Despite the losses, the index is still up more than 76% since bottoming in late October.

Unlike in May, stocks listed primarily on the OTC lagged Canadian stocks, especially the licensed producers. The index ended with 67.4% of the composition in Canada, including 26.3% licensed producers. The three stocks listed on the Australian Stock Exchange accounted for 3.4%.

Eighteen companies posted gains in excess of 5%:

Among the winners, 22nd Century Group (NYSEMKTS: XXII) was the only company not domiciled in the U.S., and it benefited from its addition to the Russell 2000…

Electrum Partners is an advisory services firm specializing in
medical and adult use cannabis and ancillary businesses.
With a global reputation for innovative thinking and vision, the experienced senior leadership team takes great pride in helping to create the framework for successful business entries and exits across the full spectrum of cannabis business verticals. We also have deep experience in helping develop policy and regulatory frameworks with an acute understanding and knowledge of regulatory complexities.
To learn more, we invite you to visit us at electrumpartners.com

Electrum Partners is an advisory services firm specializing in medical and adult use cannabis and ancillary businesses.
Electrum collaborates with private and public companies looking to raise capital and improve shareholder value and liquidity. We are trusted advisors to policy-makers and governments looking affect meaningful change, investors looking to maximize their returns, and companies looking to make the private-to-public transition. Let’s talk about how we can work together.